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sample was reduced to a still balanced subsample of 70 patients. VAS ratings were 
transformed into utilities by specifying a power function. A multiplicative-form MAUF 
was estimated following the standard methodology. RESULTS: Individual utilities 
from TOOL MAUF showed adequate unbiased predictive validity. Good convergent 
validity was evidenced, since estimated utilities presented strong correlations with 
utilities from generic HRQoL instruments: SF6D (0.664, p  0.001), EQ5D (0.690, p 
 0.001)); and moderate correlations with the rest of instruments included: PANSS 
(0.275, p  0.100), YMRS (0.296, p  0.080), MADRS (0.483, p  0.001), UKU 
(0.424, p  0.002). Criterion validity was also met, as differences in mean utilities 
by clinical severity were found (p  0.008). Interestingly, utilities from TOOL MAUF 
covered a wider range of health states (0.037, 1.000) than those from SF6D and EQ5D 
(0.233, 0.960), since TOOL is a speciﬁc instrument. CONCLUSIONS: Utilities from 
TOOL MAUF show good psychometric properties and cover a wider range of health 
states than utilities from other generic HRQoL instruments.
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OBJECTIVES: The purpose of this study was to describe the current situation of Post 
Traumatic Stress Disorder (PTSD) among Hungarian prehospital ambulance staff and 
make suggestions for the workplace. METHODS: In the study we involved 60 persons 
at ﬁve ambulance station in Pest county randomly. Standardized self-ﬁll-in PTSD and 
burn out questionnaire were used in an interview process to collect information. The 
items included PTSD symptoms, coping mechanisms, social support and burn out. 
Data collection was carried out in 2008 and statistical analysis as one-way analysis 
of variance (ANOVA) was performed with SPSS 14.0. RESULTS: All respondents 
were male with an average age 33,2 years. More than two third (66.7%) of all people 
spent 1–5 years with ambulance service. Eightoeen out of 60 suffer on a chronic condi-
tion, mainly in locomotion system. The PTSD symptoms are present in 17 (28.3%) 
ambulance man and they can get support from colleagues (75%), family (66.7%) and 
friends (58.35) and very rearly from professionals, like psychologist (6.7%). The 
respondents indicated “No one would help” in 8,3%. Regarding to burn out: 15% is 
in danger, in 5% in burnt out. The half of the respondents are at risk of symptoms 
of burn out. The symptoms of PTSD and burn out correlated with no active sport 
(p  0.05), with a second job (p  0.05) and poor working conditions (p  0.05). 
CONCLUSIONS: The results showed a high percentage of PTSD symptoms and 
risk of burn out which needs already treatment. Health promotion at work place, 
coaching techniques and a pschychologist at work place can provide a better outcome 
for ambulance personnel.
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OBJECTIVES: To evaluate in a cohort of depressed patients if response within the 
ﬁrst 6 weeks of antidepressant treatment (AD) is associated with a change in health-
related quality of life (HRQoL) after 1-year follow-up. METHODS: This is a 1-year, 
longitudinal, prospective and multicenter study of a cohort of outpatients with major 
depression. Main objective was to assess the predictive value of early antidepressant 
response in long-term good outcome. Patients were included when they started an AD 
for index episode. Early response was deﬁned as a 50% improvement on the 17-Item 
Hamilton Depression Rating Scale total score (HAM-D17) within the ﬁrst 6 weeks, 
and good outcome when the patient achieved remission (HAM-D17 a7) in the ﬁrst 6 
months and remained in remission until end of follow-up. HRQoL was scored by the 
European Quality of Life-5 Dimensions (EQ-5D). The change of the scoring from 
baseline to end of follow-up in the EuroQol was analyzed by means of an ANCOVA 
model. RESULTS: 930 patients were included in the study. At baseline, mean age was 
47.1 years (SD, 13.5), 67.9% were female and mean HAM-D17 score was 24.2 (SD, 
5.5). 355 patients (38.2%) showed early response and of those 76.1% had a good 
outcome, versus 43% of those patients without early response. The baseline EQ-5D 
index raw scores (95% Conﬁdence interval, CI) improved from 0.25 (0.22–0.29) to 
0.91 (0.89–0.93) among patients who showed early response, and from 0.23 (0.21–
0.26) to 0.81 (0.79–0.83) among those without it. Improvement in EQ-5D scores was 
associated with early response, gender, having lower baseline HRQoL (EQ-5D), higher 
depressive scores (HAM-D17) and higher level of anxiety (HAM-A). Moreover there 
were interactions found between gender and early response. CONCLUSIONS: 
Depressed patients experienced improvements in HRQoL after starting AD. This 
improvement was associated with early antidepressant response.
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OBJECTIVES: Olanzapine Long-Acting Injection (OLAI) was developed to provide 
individuals with schizophrenia, particularly those who struggle with adherence, with 
an effective and convenient alternative to oral antipsychotics. The present study com-
pared quality of life and patient-reported outcomes between oral and long-acting 
injectable formulations of olanzapine in the treatment of schizophrenia. METHODS: 
Clinician-rated quality of life and patient-reported outcomes were evaluated in a 24-
week double-blind, randomized clinical trial comparing OLAI with oral olanzapine in 
clinically stabilized individuals with schizophrenia. The measures used included the 
Heinrichs-Carpenter Quality of Life Scale (QLS), the Short Form Health Survey (SF-
36), and the Drug Attitude Inventory (DAI). RESULTS: Of the 1065 randomized 
individuals, the majority were male (65.4%) and Caucasian (71.8%), with a mean 
age of 39 years and a baseline PANSS Total score of 55.9 (SD  15.6). In general 
changes in QLS, SF-36, and DAI for individuals on OLAI were similar to those for 
individuals receiving oral olanzapine with the exception of statistically signiﬁcant dif-
ferences on some SF-36 subscales. However these differences across treatment groups 
were not considered clinically meaningful. Despite examination in a symptomatically 
stable population, signiﬁcant improvements in quality of life as measured by the QLS 
total scores were seen in the group taking OLAI for two of the three therapeutic doses 
(405 mg/4 wk, p  0.001 and 300 mg/2 wk, p  0.003) and the group taking oral 
olanzapine (p  0.001). There were no signiﬁcant differences in QLS across treatment 
groups. CONCLUSIONS: Subjects remained stable over the course of the study, and 
many experienced an increase in quality of life regardless of assignment to OLAI or 
oral olanzapine. The ﬁndings suggest symptomatically stable individuals receiving 
OLAI will maintain health outcomes comparable with those taking oral olanzapine. 
OLAI may be useful for individuals who desire the effectiveness of olanzapine without 
requiring daily dosing.
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OBJECTIVES: To investigate the health status and quality of life of demented patients 
in Hungary, examining the correlation between disease characteristics and quality of 
life (QoL). Also to compare QoL results of the demented patients with the general 
Hungarian population’s scores by age-groups. METHODS: A cross-sectional study of 
88 consecutive patients was conducted in 2008 involving 3 GP and 1 outpatient set-
tings. Investigating the health related quality of life, EuroQoL (EQ-5D) questionnaire 
was applied and completed by assistants’ guidance. Mini-Mental State Examination 
(MMSE) and Resource Utilization in Dementia (RUD) questionnaire were completed 
as well. Negatives EQ-5D scores were replaced by 0. Spearman correlation coefﬁcients 
were performed. RESULTS: Eighty-eight patients (59% female) were involved in the 
survey with mean age of 78 years (SD 8.5) and average disease duration of 4.3 years 
(SD 5.1). Mean MMSE was 16.7 (SD 7.24) and EQ-5D score was 0.401 (SD 0.327). 
Average EQ-5D values of the general Hungarian population aged 65–74, 75–85 and 
85 years were 0.756, 0.634 and 0.629, respectively, whilst these values were 0.530, 
0.424 and 0.220 in our sample. Signiﬁcant correlation was observed between EQ-5D 
score and disease duration, MMSE score, and the time-resource utilization (physical 
and instrumental activities of daily living as well as supervision hours), at p  0.01. 
For mild (MMSE 18–23), moderate (MMSE 10–17) and severe (MMSE 0–9) dementia 
the EQ-5D values decreased by disease severity, with mean values of 0.56 (SD. 0.28), 
0.29 (SD. 0.32) and 0.19 (SD. 0.31), respectively. Although for mild cognitive impair-
ment (MMSE 24–30) it resulted in lower values than in mild dementia, with mean 
0.53 (SD. 0.33) CONCLUSIONS: Dementia causes a signiﬁcant decline in the quality 
of life, diminishing EQ-5D values by disease severity. EQ-5D values are remarkably 
lower in all age groups among demented people compared to general population.
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OBJECTIVES: While the effects of dementia on patients are well documented, aware-
ness of its negative impact on the life of caregivers needs to be increased. The objective 
of this survey was to provide data from physicians and caregivers on the impact of 
dementia on both patients and carers. METHODS: Adelphi’s Dementia Disease Spe-
ciﬁc Programme is an independent real world observational survey of cognitively 
impaired patients aged over 50 managed by primary or secondary care physicians in 
ﬁve European countries during 2008. Information from non-professional caregivers 
was collected using a prospective questionnaire including details of employment status, 
patient accommodation, patient’s current symptoms, patient compliance with treat-
ment and the carer’s quality of life measured by a validated instrument (Zarit Care-
giver Burden Interview). RESULTS: The caregiver questionnaires (n  847) showed 
